SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-312895
Filing Date
2020-12-08
Accepted
2020-12-08 17:25:54
Documents
5
Period of Report
2020-12-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d66270d8k.htm 8-K 20741
2 EX-3.1 d66270dex31.htm EX-3.1 24348
3 EX-3.2 d66270dex32.htm EX-3.2 122040
4 EX-99.1 d66270dex991.htm EX-99.1 4741
5 GRAPHIC g66270g77a86.jpg GRAPHIC 6365
  Complete submission text file 0001193125-20-312895.txt   181968
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 201376156
SIC: 2834 Pharmaceutical Preparations